Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Family Medicine | ENT | Pediatrics | Journal

Back to Journal Articles

Updated Recommendations for Sleep Apnea in Children

Last Updated: August 27, 2012.

 

American Academy of Pediatrics revises clinical practice guidelines

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
The American Academy of Pediatrics is revising its recommendations for the diagnosis and management of obstructive sleep apnea syndrome in children and adolescents, according to a clinical practice guideline published online Aug. 27 in Pediatrics.

MONDAY, Aug. 27 (HealthDay News) -- The American Academy of Pediatrics (AAP) is revising its recommendations for the diagnosis and management of obstructive sleep apnea syndrome (OSAS) in children and adolescents, according to a clinical practice guideline published online Aug. 27 in Pediatrics.

Carole L. Marcus, M.B.B.Ch., from the AAP's Subcommittee on Obstructive Sleep Apnea Syndrome, and colleagues reviewed 350 relevant articles from 1999 to 2010, most of which were level II to IV, and used these data to revise the clinical practice guidelines.

The subcommittee recommends that all children/adolescents be screened for snoring, and that polysomnography should be performed in children/adolescents with snoring and symptoms/signs of OSAS. Adenotonsillectomy is the first-line treatment of choice for patients with adenotonsillar hypertrophy, with reevaluation recommended postoperatively to determine whether further treatment is required. If adenotonsillectomy is not performed or if OSAS persists postoperatively, continuous positive airway pressure is recommended as a treatment. For overweight or obese patients, weight loss is recommended in addition to other therapy. For children with mild OSAS in whom adenotonsillectomy is contraindicated or for mild postoperative OSAS, intranasal corticosteroids should be considered.

"There is a great need for further research into the prevalence of OSAS, sequelae of OSAS, best treatment methods, and the role of obesity," Marcus and colleagues conclude.

Several subcommittee members disclosed financial ties to the pharmaceutical and respiratory device industries.

Abstract
Full Text

Copyright © 2012 HealthDay. All rights reserved.


Previous: Kyphoplasty Superior to Vertebroplasty for Vertebral Fx Next: Poorer Bone Health Seen in Black Children With Fractures

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.